Amira Raudhah Raudhah Abdullah

Dr. Amira Raudhah Raudhah Abdullah

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
AAAmira Raudhah Raudhah Abdullah
Amira Raudhah Raudhah Abdullah
Hermizi HapidinHermizi Hapidin
Hermizi Hapidin
HAHasmah Abdullah
Hasmah Abdullah
Background. Quercus infectoria (QI) is a plant used in traditional medicines in Asia. The plant was reported to contain various active phytochemical compounds that have potential to stimulate bone formation. However, the precise mechanism of the stimulation effect of QI on osteoblast has not been elucidated. The present study was carried out to isolate QI semipurified fractions from aqueous QI extract and to delineate the molecular mechanism of QI semipurified fraction that enhanced bone formation by using hFOB1.19 human fetal osteoblast cell model. Methods. Isolation of QI semipurified fractions was established by means of column chromatography and thin layer chromatography. Established QI semipurified fractions were identified using Liquid Chromatography‐Mass Spectrometry (LC‐MS). Cells were treated with derived QI semipurified fractions and investigated for mineralization deposition and protein expression level of BMP‐2, Runx2, and OPN by ELISA followed gene expression analysis of BMP‐2 and Runx2 by RT‐PCR. Results. Column chromatography isolation and purification yield Fractions A, B, and C. LC‐MS analysis reveals the presence of polyphenols in each fraction. Results show that QI semipurified fractions increased the activity and upregulated the gene expression of BMP‐2 and Runx2 at day 1, day 3, and day 7. OPN activity increased in cells treated with QI semipurified fractions at day 1 and day 3. Meanwhile, at day 7, expression of OPN decreased in activity. Furthermore, the study showed that combination of Fractions A, B, and C with osteoporotic drug (pamidronate) further increased the activity and upregulated the gene expression of BMP‐2 and Runx2. Conclusions. These findings demonstrated that polyphenols from semipurified fractions of QI enhanced bone formation through expression of the investigated bone‐related marker that is its potential role when combined with readily available osteoporotic drug.

27 May 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
MAMaria Arshad
Maria Arshad
AAAmira Raudhah Raudhah Abdullah
Amira Raudhah Raudhah Abdullah
FIFuad Ismail
Fuad Ismail
Francesco PezzellaFrancesco Pezzella
Francesco Pezzella
AYAzyani Yahaya
Azyani Yahaya
KTKa-Liong Tan
Ka-Liong Tan
Introduction: NEDD8 Ultimate Buster 1 (NUB1) is a regulator of the cell cycle and a prognostic marker in cancer patients. However, its role in breast cancer (BC) and its response to 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) treatment remain unclear. This study investigated NUB1’s predictive value in FEC treatment and its mechanistic interaction with the oestrogen receptor (ER) in BC. Methods: MDA-MB-231 and MCF-7 cells were treated with FEC and analysed via flow cytometry for cell cycle distribution. Western blotting assessed NUB1 and ERα expression, while immunohistochemistry was conducted on a retrospective cohort (n = 85) from Malaysian hospitals to evaluate the clinical significance of NUB1 expression. Results: FEC treatment induced S and G2 phase cell cycle arrest in MDA-MB-231 cells (p = 0.04 and p = 0.02, respectively), accompanied by NUB1 upregulation. In MCF-7 cells, G2/M arrest was observed (p = 0.01), with reduced ERα expression and increased NUB1 levels in both cell lines. Lower cytoplasmic NUB1 expression was associated with poorer overall survival (OS) (HR = 0.60; 95% CI = 0.32–1.11; p = 0.10). Patients with low NUB1 and low ER expression showed the worst OS outcomes. Discussion: NUB1 upregulation following FEC treatment led to cell cycle arrest in ER-negative cells, whereas ERα suppression failed to induce S-phase arrest in ER-positive cells. Low NUB1 expression predicted poorer OS and increased BC recurrence. Conclusions: By integrating in vitro and clinical data, this study suggests that NUB1 may serve as a predictive biomarker in FEC-treated breast cancer. Larger studies are needed to validate and establish NUB1’s predictive role in FEC-treated patients.

31 January 2021 in Malaysian Journal of Science Health & Technology
Verified
Journal Article
Open access
PDF file
AHAzimah Ahmad Zainol Hady
Azimah Ahmad Zainol Hady
LALiyana Azmi
Liyana Azmi
AAAmira Raudhah Raudhah Abdullah
Amira Raudhah Raudhah Abdullah
Bone can heal on its own through the process known as bone remodelling. Nonetheless, a critical size bone defect will hinder the natural bone-healing process and may not allow for complete fracture healing. These requires surgical intervention by employing the use of bone tissue implants and in need of realignment and fixation for proper fracture healing. Traditional knowledge of bone injury and fracture healing must be comprehended thoroughly for a proper invention of bioengineered material or devices that could enhance the physiological process. Heretofore, engineered materials used to address critical size bone defects have encountered various challenges and improvement be it in bone grafting or choices of mechanical stabilization devices. To date, researchers have been mainly focussing on the alternative material for bone graft substitute albeit the selection of fixators to establish mechanical stabilization are as important. This review highlighted the challenges, improvement and advancement in mechanical stabilization devices and bone graft substitute with respect to the physiological process of bone fracture healing. Identifying these challenges would help assist the researcher in an expedition toward the recovery and restoration of critical size bone defects.

10 October 2023 in Pharmacy Education
Verified
Journal Article
Open access
PDF file
MMMusa Intan Maslina
Musa Intan Maslina
AAAmira Raudhah Raudhah Abdullah
Amira Raudhah Raudhah Abdullah
Background: Engineered bone tissue, made up of hydroxyapatite (HA) scaffold is the current alternative in bone transplant. The scaffold needs to mimic the extracellular matrix (ECM) to support bone growth and repair. Vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2) are vital in producing a suitable ECM environment to promote bone regeneration. Objective: To elucidate the synergistic effect of VEGF and BMP-2 growth factors on MC3T3-E1 osteoblast cells. Method: MC3T3-E1 cells were cultured in vitro and seeded onto a HA scaffold supplied with VEGF and BMP-2 growth factors. The characterisation of its mineralisation was evaluated on Day three and Day seven using the Alizarin Red staining (ARS) technique. Result: Positive ARS staining was observed in the HA scaffold supplied with VEGF and BMP-2 growth factors in vitro, thus indicating that a high level of calcium was deposited. These results suggest that the combined use of VEGF and BMP-2 will increase cell proliferation and osteoblast differentiation in vitro. Conclusion: Therefore, the synergistic effects of VEGF and BMP-2-loaded HA scaffold confirm the process as a promising approach to enhance the osteogenic effect and support cellular functions of osteoblastic cells in bone tissue engineering applications.

31 October 2025 in International Journal Of Community Medicine And Public Health
Verified
Journal Article
Open access
PDF file
AAAmira Raudhah Raudhah Abdullah
Amira Raudhah Raudhah Abdullah
LALiyana Azmi
Liyana Azmi
MAMuhamad Afiq Aziz
Muhamad Afiq Aziz
NANur Waliyuddin Hanis Zainal Abidin
Nur Waliyuddin Hanis Zainal Abidin
MJMuhammad Idham Jasmiad
Muhammad Idham Jasmiad
The COVID-19 pandemic led to increased global use of alcohol-based hand sanitizers (ABHS) and disinfectants as key infection control measures. While initially implemented as emergency measures, their continued and widespread use in healthcare and community settings has raised concerns regarding long-term safety and environmental impact. This systematic review aimed to evaluate the adverse health effects associated with ABHS and disinfectants beyond the pandemic phase. Following PRISMA guidelines, a comprehensive search of PubMed, Google Scholar and Scopus identified studies published between 2014 and 2025. Eleven studies met inclusion criteria, focusing on chemical composition, exposure routes and the toxicological outcomes. Evidence shows that dermal absorption, inhalation, ingestion and ocular contact are the main exposure pathways to ABHS and disinfectant. Meanwhile, reported health effects ranging from mild dermatitis to systemic toxicity. Chemicals such as methanol, quaternary ammonium compounds (QACs) and chlorine-based disinfectants were most often linked to respiratory problems, neurological effects, reproductive risks as well as pose risk as environmental contamination. Children, pregnant women, and healthcare workers were found to be especially vulnerable. Weak regulatory oversight during the pandemic contributed to the circulation of substandard or counterfeit products, adding to the risks. The ongoing high use of ABHS and disinfectants in 2025 underscores the importance of stronger regulations, clearer labelling, better quality control, and continuous public education. Moving forward, safer alternatives and sustainable hygiene practices are needed to maintain effective infection prevention while minimizing risks to health and the environment.

5 September 2017 in Biomedical Research and Therapy
Verified
Journal Article
Open access
AAAmira Raudhah Raudhah Abdullah
Amira Raudhah Raudhah Abdullah
HHHermizi Hapidin
Hermizi Hapidin
HAHasmah Abdullah
Hasmah Abdullah
Quercus infectoria (QI) is traditional medicines in Asia which contain many active phytochemical compounds that have the potential to stimulate bone formation. However, the precise mechanism of the therapeutic effect of QI on osteoblast has not been elucidated. The present study was carried out to extract the active compound of QI through a series of purification in order to obtain semi-purified fractions of QI followed by examining its phytochemical profile through liquid chromatography mass spectrometry (LC-MS) as well as to delineate the molecular mechanism of QI semi-purified fraction-enhanced bone formation by investigating the protein expression of bone morphogenic protein-2 (BMP-2), Runx2 and osteopontin (OPN) in the hFOB 1.19 human fetal osteoblastic cell line. The semi-purified fractions of QI were produced in series of column chromatography and thin layer chromatography (TLC) technique. The obtained fractions were then tested in a series of bio-guided assay through MTT assay. Three most potent fractions with lowest EC50 value (Fraction A-10.85 µg/ml, Fraction B-12.00 µg/ml and Fraction C-11.60 µg/ml) were selected to be treated with hFOB1.19 cell followed by quantification of BMP-2, Runx2 and OPN protein expression at day 1, 3 and 7. Compound profiling through LC-MS analysis showed that the chosen fractions consist of main active component known as gallic acid that has been showed previously to promote bone formation. Results show that QI semi-purified fractions increased the activity of BMP-2, Runx2 and OPN at day 1 and day 3. Meanwhile as the expression of BMP-2 and Runx2 continue to increase at day 7, the expression of OPN shows a down regulation at day 7. Furthermore, the study showed that combination of Fraction A, B and C wit osteoporotic drug (pamidronate) further increase the expression of BMP-2 and Runx2 contrary to OPN expression. These finding demonstrated that semi-purified fraction of QI enhanced bone formation through expression of investigated bone-related marker.